How many years you can live on crizotinib needs to depend on the specific disease, the effectiveness of treatment, and compliance with medical advice. In most patients, 5 to 8 years of survival is possible with active treatment. Crizotinib common adverse reactions are nausea, vomiting, diarrhea, constipation, edema and so on. It needs to be contraindicated for severe liver damage and for pregnant and lactating women. The drug can be used for localized early or metastatic non-small cell lung cancer that is positive for the kinase of mesenchymal lymphoma. Among the non-small cell lung cancer stage I patients, the 5-year survival rate is 60-80%, while the 5-year survival rate of stage IV patients is less than 5%. If patients actively cooperate with doctors and take the right medication, the survival period will be greatly prolonged. It is recommended to consult a doctor to determine the survival rate in the light of one’s own personal situation. No matter what the situation is, the patient should be actively treated to improve the quality of life and prolong the survival period.